NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
TOP NEWS
»08/02/2010 [Industry news]
There will be blood... Shenzhen Guangming plans new plasma product facility

Shenzhen Weiwu Guangming Biological Products announced February 3 that it will invest RMB 170 million to build the largest blood-products production base in southern China according to,www.qq.com.

 
Shenzhen Weiwu Guangming Biological Products announced February 3 that it will invest RMB 170 million to build the largest blood-products production base in southern China according to,www.qq.com. Guangming Biological Products will establish a new 16,000 square-meter blood-products line within the pre-existing factory location. After the completion of the project, the annual handling capacity of blood plasma will reach 300 tons with a production value of nearly RMB 300 million. Shenzhen WeiWu Guangming Biological Products has specialized in the development and production of biological products for 20 years, and is one of the largest blood product companies in Guangdong Province. According to GBI SOURCE, the company currently has nine products registered in China including albumin and human immunoglobulins.

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.